 |
|
Comparison of Outcomes Using 2 Delivery Models of Anticoagulation Care
Anthony G. Staresinic, PharmD;
Christine A. Sorkness, PharmD;
Brian M. Goodman, PhD;
Denise Walbrandt Pigarelli, PharmD
Arch Intern Med. 2006;166:997-1002.
Background Studies demonstrate the effectiveness of anticoagulation management service (AMS) in providing antithrombotic therapy for eligible patients. We sought to extend this concept by determining whether an interim telephone model (IT) is comparable to our current AMS model at achieving optimal therapeutic outcomes.
Methods The 36-month trial (24-month study plus 12-month extension) enrolled 192 eligible patients receiving long-term warfarin therapy at a Veterans Affairs hospital. Consenting participants were randomly assigned to either our current face-to-face clinic model (AMS), or our IT model. The primary outcome was the percentage of time individuals' international normalized ratios (INRs) were maintained within their target INR range (2.0-3.0 or 2.5-3.5). Secondary outcomes included the number of adverse events (eg, thromboembolism or hemorrhage) experienced during the study.
Results We found no statistically significant difference between the 2 groups in the percentage of time maintained within INR target range overall (55.1% for AMS; 57.8% for IT; P = .28) nor over the course of the study. There were no statistically significant differences in the rate of thromboembolic or serious bleeding events between IT and AMS participants. Nevertheless, we did note differences related to intensity of anticoagulation. The IT group receiving treatment at a higher intensity (INR, 2.5-3.5) experienced greater anticoagulation control (P = .04) and fewer complications than the AMS group. The IT participants, however, reported a significantly higher rate of minor bleeding events, experienced mainly by those at an INR range of 2.0 to 3.0.
Conclusion Our IT model is a viable modification of our AMS model for the management of patients undergoing chronic anticoagulant therapy.
Author Affiliations: Pharmacy Practice Division, University of Wisconsin School of Pharmacy (Drs Staresinic, Sorkness, Goodman, and Pigarelli), and William S. Middleton Veterans Affairs Hospital (Drs Sorkness and Pigarelli), Madison, Wis. Dr Staresinic is now with Navitus Health Solutions, Madison, Wis.
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Quality of Clinical Documentation and Anticoagulation Control in Patients With Chronic Nonvalvular Atrial Fibrillation in Routine Medical Care
Ansell et al.
American Journal of Medical Quality 2007;22:327-333.
ABSTRACT
|
